Research Article
Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
Table 2
BAP1 status in histology and cytology specimens.
| BAP1 status | Surgical | Cytology | Negative | Positive | Negative | Positive |
| Total | 47 (58%) | 34 (42%) | 34 (59%) | 23 (41%) | Gender | | | | | Male | 39 (62%) | 24 (38%) | 30 (65%) | 16 (35%) | Female | 8 (44%) | 10 (56%) | 4 (36%) | 7 (64%) | Age | | | | | Median (range) | 74 (53–92) | 74 (35–91) | 74 (53–92) | 74 (35–91) | Subtype | | | | | Epithelioid | 35 (61%) | 22 (39%) | 27 (63%) | 16 (37%) | Biphasic | 8 (62%) | 5 (38%) | 4 (57%) | 3 (43%) | Sarcomatoid | 4 (36%) | 7 (64%) | 3 (43%) | 4 (57%) | Location | | | | | Pleural | 47 (59%) | 33 (41%) | 34 (61%) | 22 (39%) | Peritoneal | 0 | 1 (100%) | 0 | 1 (100%) |
|
|